Eva Holtl
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray.
Journal: Vaccines
Published: December 04, 2023
A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection.
Journal: Diagnostics (Basel, Switzerland)
Published: June 12, 2023
Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference.
Journal: Microbiology spectrum
Published: January 09, 2023
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant.
Journal: Microbiology spectrum
Published: August 25, 2022
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
Journal: Frontiers in immunology
Published: May 17, 2022
SARS-CoV-2-Specific Antibody (Ab) Levels and the Kinetic of Ab Decline Determine Ab Persistence Over 1 Year.
Journal: Frontiers in medicine
Published: November 25, 2021
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults.
Journal: Communications medicine
Published: January 27, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026